174 related articles for article (PubMed ID: 11291807)
1. Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously.
Vereckei A; Warman E; Mehra R; Zipes DP
J Cardiovasc Electrophysiol; 2001 Mar; 12(3):330-6. PubMed ID: 11291807
[TBL] [Abstract][Full Text] [Related]
2. Intrapericardial ibutilide administration fails to terminate pacing-induced sustained atrial fibrillation in dogs.
Vereckei A; Gorski JC; Ujhelyi M; Mehra R; Zipes DP
Cardiovasc Drugs Ther; 2004 Jul; 18(4):269-77. PubMed ID: 15367824
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
Stambler BS; Wood MA; Ellenbogen KA
Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing.
Stambler BS; Wood MA; Ellenbogen KA
Am J Cardiol; 1996 May; 77(11):960-6. PubMed ID: 8644646
[TBL] [Abstract][Full Text] [Related]
5. Comparison of right atrial and peripheral procainamide infusion levels in patients with spontaneous or induced atrial fibrillation.
Lurie KG; Buscemi PJ; Iskos D; Adkisson W; Fahy GJ; Sakaguchi S; Hoff J; Benditt DG
Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):277-83. PubMed ID: 9474688
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravenous amiodarone and ibutilide on action potential duration and atrial conduction kinetics in patients with persistent atrial fibrillation.
Sasaki N; Watanabe I; Kogawa R; Sonoda K; Takahashi K; Okumura Y; Ohkubo K; Nakai T; Hirayama A
Int Heart J; 2014; 55(3):244-8. PubMed ID: 24806377
[TBL] [Abstract][Full Text] [Related]
7. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR
J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
[TBL] [Abstract][Full Text] [Related]
9. Rapid drug infusion for termination of atrial fibrillation in an experimental model.
Arzbaecher R; Gemperline J; Haklin M; Buscemi P
Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):288-91. PubMed ID: 9474690
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
[TBL] [Abstract][Full Text] [Related]
11. Prevention of acute inducible atrial flutter in dogs by using an ibutilide-polymer-coated pacing electrode.
Labhasetwar V; Strickberger SA; Underwood T; Davis J; Levy RJ
J Cardiovasc Pharmacol; 1998 Mar; 31(3):449-55. PubMed ID: 9514191
[TBL] [Abstract][Full Text] [Related]
12. Effects of procainamide on electrical activity in thoracic veins and atria in canine model of sustained atrial fibrillation.
Chou CC; Zhou S; Miyauchi Y; Pak HN; Okuyama Y; Fishbein MC; Karagueuzian HS; Chen PS
Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1936-45. PubMed ID: 15072975
[TBL] [Abstract][Full Text] [Related]
13. Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis.
Pagé PL; Hassanalizadeh H; Cardinal R
Can J Physiol Pharmacol; 1991 Jan; 69(1):15-24. PubMed ID: 2036596
[TBL] [Abstract][Full Text] [Related]
14. Effect of ibutilide, a new class III agent, on sustained atrial fibrillation in a canine model of acute ischemia and myocardial dysfunction induced by microembolization.
Nabih MA; Prcevski P; Fromm BS; Lavine SJ; Elnabtity M; Munir A; Steinman RT; Meissner MD; Lehmann MH
Pacing Clin Electrophysiol; 1993 Oct; 16(10):1975-83. PubMed ID: 7694244
[TBL] [Abstract][Full Text] [Related]
15. Rate-dependent electrophysiologic effects of the class III antiarrhythmic drugs nifekalant, amiodarone, and ibutilide on the atrium in patients with persistent atrial fibrillation.
Sonoda K; Watanabe I; Ohkubo K; Okumura Y; Kofune M; Sasaki N; Kogawa R; Mano H; Nakai T; Hirayama A
Int Heart J; 2013; 54(5):279-84. PubMed ID: 24097216
[TBL] [Abstract][Full Text] [Related]
16. Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
Yu WC; Chen SA; Lee SH; Tai CT; Feng AN; Kuo BI; Ding YA; Chang MS
Circulation; 1998 Jun; 97(23):2331-7. PubMed ID: 9639377
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic enhancement of atrial electrical defibrillation efficacy: role of ibutilide.
Khoury DS; Assar MD; Sun H
J Interv Card Electrophysiol; 1997 Dec; 1(4):291-8. PubMed ID: 9869983
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
[TBL] [Abstract][Full Text] [Related]
19. Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness.
Sticherling C; Hsu W; Tada H; Bares AC; Oral H; Pelosi F; Knight BP; Strickberger SA; Morady F
J Cardiovasc Electrophysiol; 2002 Feb; 13(2):151-7. PubMed ID: 11900290
[TBL] [Abstract][Full Text] [Related]
20. Conversion of atrial fibrillation to sinus rhythm using acute intravenous procainamide infusion.
Kochiadakis GE; Igoumenidis NE; Solomou MC; Parthenakis FI; Christakis-Hampsas MG; Chlouverakis GI; Tsatsakis AM; Vardas PE
Cardiovasc Drugs Ther; 1998 Mar; 12(1):75-81. PubMed ID: 9607135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
